Professional background
Dr Dionysis Papadatos-Pastos is a highly experienced consultant oncologist in London, specialising in the treatment of lung cancer, mesothelioma, and thymic tumours. He serves as Lung Cancer Lead at the Cancer Research UK UCL Clinical Trials Centre, where he plays a key role in developing and delivering innovative cancer therapies.
With extensive expertise in immunotherapy, targeted therapies, and chemotherapy, Dr Papadatos-Pastos is widely recognised for combining advanced science with compassionate, patient-centred care.
He graduated in medicine with distinction from the University of Athens, before completing a PhD in Medical Oncology (First Class Honours, 2012). His specialist training in medical oncology took place at leading UK centres, including The Royal Marsden and Guy’s and St Thomas’ Hospital.
He also holds a diploma in medical oncology from the Institute of Cancer Research, University of London. An active researcher, Dr Papadatos-Pastos has served as principal investigator on multiple clinical trials, with a strong interest in early drug development. He has presented his research internationally and published widely in peer-reviewed medical journals, particularly on the development of novel targeted therapies and immunotherapy combinations for lung cancer. Patients value his clear communication, academic authority, and commitment to delivering the latest world-class cancer treatments in London.
Specialties
Research interests
Dr Papadatos-Pastos' research focuses on advancing lung cancer treatment in London, with a special interest in developing targeted therapies and immunotherapy for lung cancer, mesothelioma, and thymic tumours. He is actively involved in early clinical trials in thoracic oncology, helping bring the newest cancer treatments from research into real patient care.
Languages spoken
Greek